In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer

Reija Randen-Brady; Timo Carpen; Lauri Jouhi; Stina Syrjänen; Caj Haglund; Jussi Tarkkanen; Satu Remes; Antti Mäkitie; Petri S. Mattila; Suvi Silen; Jaana Hagström

doi:10.1016/j.humpath.2019.05.006

In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer

Reija Randen-Brady, Timo Carpen, Lauri Jouhi, Stina Syrjänen, Caj Haglund, Jussi Tarkkanen, Satu Remes, Antti Mäkitie, Petri S. Mattila, Suvi Silen, Jaana Hagström

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Human Pathology
Volym	90
Sidor (från-till)	97-105
Antal sidor	9
ISSN	0046-8177
DOI	https://doi.org/10.1016/j.humpath.2019.05.006
Status	Publicerad - aug 2019
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3111 Biomedicinska vetenskaper

Åtkomst av dokument

10.1016/j.humpath.2019.05.006

In situ hybridization for high-risk HPV E6 E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancerAccepterat manuskript från författare, 780 KBLicens: CC BY-NC-ND
1-s2.0-S0046817719300917-mainSlutlig publicerad version, 2,05 MB

Citera det här

Randen-Brady, R., Carpen, T., Jouhi, L., Syrjänen, S., Haglund, C., Tarkkanen, J., Remes, S., Mäkitie, A., Mattila, P. S., Silen, S., & Hagström, J. (2019). In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer. Human Pathology, 90, 97-105. https://doi.org/10.1016/j.humpath.2019.05.006

Randen-Brady, Reija ; Carpen, Timo ; Jouhi, Lauri ; Syrjänen, Stina ; Haglund, Caj ; Tarkkanen, Jussi ; Remes, Satu ; Mäkitie, Antti ; Mattila, Petri S. ; Silen, Suvi ; Hagström, Jaana. / In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer. I: Human Pathology. 2019 ; Vol. 90. s. 97-105.

@article{72551cc16f674563a7091bf1faffafc0,

title = "In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer",

keywords = "Oropharynx, Carcinoma, Viral infection, RNA, DNA, Polymerase chain reaction, SQUAMOUS-CELL CARCINOMA, TREATMENT DE-ESCALATION, HUMAN-PAPILLOMAVIRUS DETECTION, NECK-CANCER, P16 IMMUNOHISTOCHEMISTRY, CRITICAL-ISSUES, HEAD, VALIDATION, DIAGNOSIS, PCR, 3111 Biomedicine",

author = "Reija Randen-Brady and Timo Carpen and Lauri Jouhi and Stina Syrj{\"a}nen and Caj Haglund and Jussi Tarkkanen and Satu Remes and Antti M{\"a}kitie and Mattila, {Petri S.} and Suvi Silen and Jaana Hagstr{\"o}m",

year = "2019",

month = aug,

doi = "10.1016/j.humpath.2019.05.006",

language = "English",

volume = "90",

pages = "97--105",

journal = "Human Pathology",

issn = "0046-8177",

publisher = "W B SAUNDERS CO-ELSEVIER INC",

}

In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer. / Randen-Brady, Reija; Carpen, Timo; Jouhi, Lauri; Syrjänen, Stina; Haglund, Caj; Tarkkanen, Jussi; Remes, Satu ; Mäkitie, Antti ; Mattila, Petri S.; Silen, Suvi; Hagström, Jaana.

I: Human Pathology, Vol. 90, 08.2019, s. 97-105.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer

AU - Randen-Brady, Reija

AU - Carpen, Timo

AU - Jouhi, Lauri

AU - Syrjänen, Stina

AU - Haglund, Caj

AU - Tarkkanen, Jussi

AU - Remes, Satu

AU - Mäkitie, Antti

AU - Mattila, Petri S.

AU - Silen, Suvi

AU - Hagström, Jaana

PY - 2019/8

Y1 - 2019/8

KW - Oropharynx

KW - Carcinoma

KW - Viral infection

KW - RNA

KW - DNA

KW - Polymerase chain reaction

KW - SQUAMOUS-CELL CARCINOMA

KW - TREATMENT DE-ESCALATION

KW - HUMAN-PAPILLOMAVIRUS DETECTION

KW - NECK-CANCER

KW - P16 IMMUNOHISTOCHEMISTRY

KW - CRITICAL-ISSUES

KW - HEAD

KW - VALIDATION

KW - DIAGNOSIS

KW - PCR

KW - 3111 Biomedicine

U2 - 10.1016/j.humpath.2019.05.006

DO - 10.1016/j.humpath.2019.05.006

M3 - Article

VL - 90

SP - 97

EP - 105

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

ER -